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Abstract 
A novel phosphonium-type condensing reagent, 
1,3-dimethyl-2-(3-nitro-1,2,4-triazol-1-yl)-2-pyrrolidin-1-yl-1,3,2-diazaphospholidinium 
hexafluorophosphate (MNTP), was designed and synthesized. A 31P NMR study on the 
condensation reactions of phosphate, alkylphosphonate, boranophosphate, and H-phosphonate 
derivatives with an alcohol in the presence of MNTP demonstrated the versatility and the 
enhanced activity of the new condensing reagent, compared to the previously reported 
phosphonium-type condensing reagents. The mechanism of the condensation reactions 
mediated by MNTP is discussed on the basis of the 31P NMR studies and theoretical 
calculations. 
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1. Introduction 
  Phosphate esters, especially those which play important roles in cells such as nucleic 
acids,1,2 phosphoinositols,3,4 phospholipids,5 sugar phosphates,5,6 and phosphopeptides,7 are 
one class of important targets in current synthetic organic chemistry. The most frequently 
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used method to synthesize these phosphate esters as well as their analogs is the 
O-phosphitylation with phosphoramidites (the phosphoramidite method),8-11 because the 
reactions proceed rapidly and efficiently under mild acidic conditions. However, this method 
has some shortcomings. Firstly, care should be taken to store the phosphitylating reagents due 
to their instability to oxidation and hydrolysis. The reactions have to be carried out under 
strictly anhydrous conditions for the same reason. Secondly, an additional step, such as 
oxidation, sulfurization, or boronation, to transform the phosphite intermediates into the 
corresponding phosphate derivatives is required, which may cause some undesired side 
reactions depending on substrates (e.g., the dealkylation by I– and/or hydrolysis of substrates 
during oxidation with I2/H2O, the reduction of substrates caused by a boronating reagent, and 
so on).12-16  
In the course of our study to develop new synthetic methods for nucleic acid derivatives, 
we have been devoting much effort to the design and synthesis of condensing reagents for 
O-phosphorylations and O-phosphonylations, which have some advantages over the 
O-phosphitylations by the phosphoramidite method and can be appropriately chosen 
depending on target molecules.17-19 The advantages are: 1) condensation reactions can be 
carried out without strictly anhydrous conditions; 2) the phosphorylating and phosphonylating 
reagents can be stored for a long period of time without being oxidized or hydrolyzed; 3) an 
additional step, such as oxidation, is eliminated. These characteristics would enable one to 
synthesize some functionalized molecules, which are difficult to be synthesized by the 
phosphoramidite method. As such a successful result, we have developed a new 
boranophosphorylation reaction of nucleosides mediated by a condensing reagent and could 
synthesize dinucleoside boranophosphates containing four nucleobases,18,19 which were 
difficult to be synthesized by the phosphoramidite method due to serious side reactions on the 
nucleobases caused by a boronating reagent during the boronation of the phosphite 
intermediates.13-16 However, O-phosphorylations and O-phosphonylations (except for the 
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reaction of reactive H-phosphonates) suffer from the low reactivity of the phosphorylating 
and phosphonylating reagents, compared to that of phosphitylating reagents in the 
phosphoramidite method. This would be a significant drawback, especially when target 
molecules require multiple phosphorylations or phosphonylations as the synthesis of 
DNA/RNA analogs. To remedy this drawback and to develop an efficient condensing reagent 
applicable to a wide variety of phosphate derivatives, we designed a new phosphonium-type 
condensing reagent, 
1,3-dimethyl-2-(3-nitro-1,2,4-triazol-1-yl)-2-pyrrolidin-1-yl-1,3,2-diazaphospholidinium 
hexafluorophosphate (1). In this paper, we report the synthesis of 1 and its application to the 
synthesis of phosphate and phosphonate esters. The synthesis of 1 and the comparison of the 
reactivity of 1 with that of the prototype condensing reagent, 
3-nitro-1,2,4-triazol-1-yl-tris(pyrrolidin-1-yl)phosphonium hexafluorophosphate (2),19 are 
also described in detail.  
 
2. Results and discussion 
2.1. Design and synthesis of 
1,3-dimethyl-2-(3-nitro-1,2,4-triazol-1-yl)-2-pyrrolidin-1-yl-1,3,2-diazaphospholidinium 
hexafluorophosphate (MNTP) and 
3-nitro-1,2,4-triazol-1-yl-tris(pyrrolidin-1-yl)phosphonium hexafluorophosphate 
(PyNTP) 
  Phosphonium-type condensing reagents, which were originally developed for the peptide 
synthesis,20-23 have also proven to be effective for the synthesis of phosphate and phosphonate 
derivatives.17,19,24-27 For example, 
2-(benzotriazol-1-yloxy)-1,3-dimethyl-2-pyrrolidin-1-yl-1,3,2-diazaphospholidinium 
hexafluorophosphate (BOMP) (Figure 1, 3) was successfully used for the rapid formation of 
H-phosphonate diesters.17 The study showed that 3 was much more effective for the 
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activation of H-phosphonate monoesters than the parent commercially available condensing 
reagent, benzotriazol-1-yloxy-2-tris(pyrrolidin-1-yl)phosphonium hexafluorophosphate 
(PyBOP) (Figure 1, 4).21 Although 3 is one of the most active condensing reagents at present, 
we considered that further improvement of the molecular structure would be necessary for the 
development of a versatile condensing reagent applicable to various phosphate and 
phosphonate esters. Although the activation of the P-O– functions of phosphates or 
phosphonates with 3 would form active intermediates, 1-benzotriazolyl phosphates or 
phosphonates, they should be much less reactive than activated H-phosphonates. Given this 
situation, we designed 
1,3-dimethyl-2-(3-nitro-1,2,4-triazol-1-yl)-2-pyrrolidin-1-yl-1,3,2-diazaphospholidinium 
hexafluorophosphate (MNTP, 1), in which 3-nitro-1,2,4-triazole was introduced in the place 
of 1-hydroxybenzotriazole in 3, as a new condensing reagent, because the effectiveness of 
3-nitro-1,2,4-triazole as a nucleophilic catalyst has already been demonstrated with the 
prototype condensing reagent,  3-nitro-1,2,4-triazol-1-yl-tris(pyrrolidin-1-yl)phosphonium 
hexafluorophosphate (PyNTP, 2),19 and because 3-nitro-1,2,4-trialzole has also been used as 
an efficient nucleophilic catalyst for O-phosphorylations and O-phosphonylations with 
conventional condensing reagents, such as 1-(mesitylenesulfonyl)-3-nitro-1,2,4-triazole 
(MSNT).28  
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Figure 1. Phosphonium-type condensing reagents. 
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The synthesis of 1 is outlined in Scheme 1. 
1,3-Dimethyl-2-pyrrolidin-1-yl-1,3,2-diazaphospholidine (8) was prepared from 
N,N’-dimethyl-1,2-ethylenediamine (5) in 3 steps,29 and 8 was allowed to react with 
3-nitro-1,2,4-triazole in the presence of carbon tetrachloride, followed by a counteranion 
exchange to give 1 as a colorless crystalline solid, which could be stored in a vial for at least 
12 months at -30 ˚C.    
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Scheme 1. Synthesis of MNTP 1. Reagents and conditions: (a) BuLi (2.1 equiv), 
Et2O–hexane, -78 ˚C then 0 ˚C, 30 min; (b) TMSCl (2.1 equiv), -78 ˚C then rt, 2 h; (c) PCl3 (1 
equiv), 0 ˚C then rt, 6 h; (d) 1-(trimethylsilyl)pyrrolidine (1 equiv), 0 ˚C then reflux, 1 h; (e) 
3-nitro-1,2,4-triazole (1 equiv), CCl4 (4 equiv), CH2Cl2, -78 ˚C, 1 h then rt, 30 min; (f) KPF6 
(1 equiv), CH3CN, rt, 1 h. 
 
PyNTP 2 could be synthesized by a much simpler protocol than that for 1 (Scheme 2). The 
nucleophilic substitution of the chloro group on the phosphorus atom of a commercially 
available condensing reagent, chlorotri(pyrrolidin-1-yl)phosphonium hexafluorophosphate 
(PyCloP, 9)22 with 3-nitro-1,2,4-triazole in the presence of NaH yielded 2 in good yield as a 
colorless crystalline solid, which could also be stored in a vial for at least 12 months at -30 
˚C.  
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Scheme 2. Synthesis of PyNTP 2.  
 
The optimized geometries of 1 and 2 calculated at the HF/6-31G* level showed that 1 was a 
little less congested around the phosphorus atom, compared to 2 (Figure 2). This reduced 
steric hindrance of 1 may have some positive effect on the reaction rate mediated by this new 
condensing reagent. 
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Figure 2. Optimized geometries of 1 and 2 calculated at the HF/6-31G* level. 
 
2.2. Condensation reactions of dimethyl phosphate in the presence of the 
phosphonium-type condensing reagents 1 and 2 
  For the validation of our molecular design of the new phosphonium-type condensing 
reagent, we chose the condensation of dimethyl phosphate 10a with 2-phenylethanol 11 as a 
simple model reaction, and compared the condensation activity of 1 with that of 2 and 3. The 
phosphate 10a was allowed to condense with 11 (1.5 equiv) in the presence of 1, 2 or 3 (3 
equiv) and a weak, less nucleophilic base, 2,6-lutidine (10 equiv), as an acid scavenger in 
CH3CN–CD3CN (4:1, v/v) at 20 ˚C, and the reactions were monitored by 31P NMR. The 
results clearly demonstrated the superiority of 1 and 2 over 3 with respect to the reaction rate 
(Figure 3). Thus, the desired phosphate triester 12a was formed in 98 and 83% yields after 
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150 min when 1 and 2 were used, respectively. In the former case, 12a was isolated in 98% 
yield after the usual work-up and purification by silica gel column chromatography. On the 
other hand, only 33% of 12a was generated within the same time period, when 3 was used.  
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Figure 3. Condensation reactions of dimethyl phosphate 10a with 2-phenylethanol 11 (1.5 
equiv) in the presence of 1, 2, or 3 (3 equiv) in CH3CN–CD3CN (4:1, v/v) at 20 ˚C. ■, MNTP 
1; ●, PyNTP 2; ▲, BOMP 3. 
 
The condensation reaction of 10a with 11 mediated by 1-3 is most likely to start with the 
generation of the active intermediate 13a,b (Figure 4). This type of active intermediates have 
also been proposed for the PyBOP-mediated activation of phosphonates.25 There are some 
possible pathways from 13a,b to the final product 12a. The pathway via the symmetric 
pyrophosphate 14a (path a) undoubtedly exists; the generation of 14a and its conversion to 
the final product 12a could be monitored by 31P NMR (14a, δ -9.6;30 12a, δ 1.9, Figure 5).31 
In the presence of 1 or 2, the rate-determining step of the path a must be the reaction of 14a 
with 3-nitro-1,2,4-triazole (Nt–H) judging from the fact that 14a was the only intermediate 
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observed by 31P NMR. However, there is not only one pathway, because the reaction rate was 
affected by the phosphonium skeleton of the condensing reagents (Figure 4, 1 vs. 2), which is 
not involved in the rate-determining step of the path a. Our assumption is that there are two 
other pathways, the paths b and c shown in Figure 4, and the rate constants of the nucleophilic 
attacks of X–H (path b) and 11 (path c) at the electronically neutral phosphorus atom of 13a 
are larger than at that of 13b. Then, we carried out the ab initio molecular orbital calculations 
(HF/6-31G* level) for 13a,b to find that the energy levels of the unoccupied molecular 
orbitals (UMOs) of 13a were lower in general than those of 13b.32 For example, the energy 
level of the lowest UMO (LUMO) of 13a was calculated to be 38.7 kcal/mol, whereas that of 
13b was 46.3 kcal/mol. The structures of 1 and 2 may also affect the rate of the nucleophilic 
attack of 10a at the electronically neutral phosphorus atoms of 13a,b (path a). However, we 
consider that the paths b and c, which should originally have larger activating energy values 
than the path a, would be relatively more affected than the path a.  
  The slow reaction mediated by 3 would be attributed to the less reactive 
benzotriazol-1-yloxy ester 15b generated from 10a and 3.33 In fact, the intermediate 15b was 
observed throughout the reaction by 31P NMR monitoring (δ 1.4) and gradually consumed to 
yield 12a,32 whereas the reactive intermediate 15a could not be detected by 31P NMR.  
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Figure 4. Possible reaction pathways for the reaction of 10a with 11 in the presence of 1, 2, 
or 3. X–H = Nt–H = 3-nitro-1,2,4-triazole for 1 and 2; X–H = BtO–H = 
1-hydroxybenzotriazole for 3.  
 
It should be noted that there was a by-product when 1 was used for the condensation 
reaction of 10a with 11. A 31P NMR analysis showed a signal at δ 34.9 (Figure 5), which was 
assigned to that of 16 by the independent reaction of 1 with 11. This side reaction was rather 
unexpected, because the nucleophilic attack of alcohols to a positively charged phosphorus 
atom assisted by a weak base, such as 2,6-lutidine, is known to be slow.17,19,25 In fact, this side 
reaction was not observed when 2 or 3 was used.34 The ratio of 16 increased upon using a 
stronger base; the ratios for 12a and 16 upon completely consuming 14a were 45:55 with 
N,N,N’,N’-tetramethyl-1,8-naphthalenediamine and 48:52 with triethylamine, while 79:21 
with 2,6-lutidine. This result suggests that the condensation of less reactive phosphates with 
sterically less hindered alcohols should be carried out using more than one molar equivalent 
of the alcohols in the absence of a strong base.  
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Figure 5. 31P NMR spectra of the reaction mixture obtained by the reaction of 10a with 11 
(1.5 equiv) in the presence of 1 (3 equiv) in CH3CN–CD3CN (4:1, v/v) at 20 ˚C. (A) 3 min; 
(B) 20 min; (C) 50 min; (D) 90 min; (E) 150 min. 
 
2.3. Application of MNTP to various phosphate and phosphonate esters 
  In the next stage, the condensation reactions of various phosphate and phosphonate 
derivatives with 11 were carried out in the presence of 1. 31P NMR monitoring studies 
demonstrated that 1 was more effective for the condensation reactions of 10b-d with 11 than 
for the reaction of 10a with 11 (Figure 6). Thus, all of the reactions of 10b-d with 11 were 
completed within 40 min; especially 10c and 10d were completely condensed within 3 min 
and 10 min, respectively. As a result, 12b and 12c were isolated in 99 and >99% yields. The 
quantitative formation of 12d was confirmed by the 31P NMR spectrum, which showed a 
newly generated signal at 10.6 ppm with a P-H coupling typical of dialkyl H-phosphonates 
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(1JPH = 691.3 Hz).32 In the cases of 10b-d, any undesired byproducts including 16 were not 
observed by 31P NMR within the period for the quantitative formation of 12b-d.32   
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Figure 6. Condensation reactions of 10a-d with 11 (1.5 equiv) in the presence of 1 (3 equiv) 
in CH3CN-CD3CN (4:1, v/v) at 20 ˚C. ■, 10a; ◆, 10b; ●, 10c; ▲, 10d. 
 
3. Conclusion 
  MNTP has proven to be a powerful condensing reagent, which mediated the rapid 
formation of various phosphate and phosphonate esters. Such versatility and enhanced 
activity of MNTP would reduce the problem of slow and inefficient reactions in the 
phosphorylation and phosphonylation of alcohols mediated by conventional condensing 
reagents and make these methods comparable to the phosphitylation by the phosphoramidite 
method. MNTP and its simpler counterpart PyNTP were found to be good alternatives to the 
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phosphoramidite method, especially for the synthesis of various functionalized phosphate 
derivatives, which are difficult to be synthesized by the phosphoramidite method. In addition 
to the synthesis of phosphate derivatives, the new phosphonium-type condensing reagents 
presented in this paper may also be useful for the rapid assembly of polypeptides as well as 
carboxylic acid esters, considering the wide-use of phosphonium-type condensing reagents 
for this purpose. 
 
4. Experimental 
4.1. General Information 
  1H NMR spectra were obtained at 300 MHz with tetramethylsilane (TMS) as an internal 
standard in CDCl3 or CD3CN. 13C NMR spectra were recorded at 75 MHz with CDCl3 as an 
internal standard (δ 77.0) in CDCl3, or with CD3CN as an internal standard (δ 117.8) in 
CD3CN. 31P NMR spectra were obtained at 121 MHz with 85% H3PO4 as an external 
standard in CDCl3 or CD3CN. Melting points were uncorrected. Silica gel column 
chromatography was carried out using silica gel 60N (63-210 µm). Organic solvents were 
purified and dried by appropriate procedures. Isolated phosphate and phosphonate derivatives 
(12a-c) were determined to be >95% pure by 1H, 13C, and 31P NMR spectroscopies.  
4.2. Ab Initio Calculations 
  Ab initio molecular orbital calculations were carried out using the Gaussian 0335 and 
Spartan ‘0436 programs on a Dell Precision 650 workstation. Geometry optimizations were 
carried out at the HF/6-31G* level. 
4.3. 1,3-Dimethyl-2-(3-nitro-1,2,4-triazol-1-yl)-2-pyrrolidin-1-yl-1,3,2- 
diazaphospholidinium hexafluorophosphate (MNTP, 1) 
  1,3-Dimethyl-2-pyrrolidin-1-yl-1,3,2-diazaphospholidine 8 (14.2 g, 76 mmol) was added 
dropwise over 2 h to a stirred solution of 3-nitro-1,2,4-triazole (8.67 g, 76 mmol), which was 
dried by repeated coevaporations with dry pyridine and dry toluene, and dry CCl4 (29.3 mL, 
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304 mmol) in dry CH2Cl2 (150 mL) at -78 ˚C under argon. The mixture was then allowed to 
warm to rt and concentrated to dryness under argon. The residue was dissolved in dry CH3CN 
(75 mL), and a solution of KPF6 (14.0 g, 76 mmol) in dry CH3CN (210 mL) was added 
dropwise over 1 h to the solution with stirring at rt under argon. The resultant white insoluble 
solid was removed by suction filtration, and the filtrate was concentrated to dryness. AcOEt 
(400 mL) was added to the residue, and the insoluble solid was collected by suction filtration, 
washed with AcOEt (50 mL), and dried under vacuum to afford 1 as a colorless crystalline 
solid (16.9 g, 38 mmol, 50%). Mp. 175-177 ˚C (decomp.). IR (KBr) 3135, 2990, 2898, 1568, 
1511, 1280, 1145, 829, 580, 558 cm-1. 1H NMR (300 MHz, CD3CN) δ 8.85 (s, 1H), 3.62-3.33 
(m, 8H), 2.89 (JPH = 11.7 Hz, 6H), 2.06 (m, 4H). 13C NMR (75 MHz, CD3CN) δ 166.2, 153.1 
(d, JPC = 7.5 Hz), 49.6, 47.5 (d, JPC = 15.0 Hz), 31.6 (d, JPC = 4.5 Hz), 27.0 (d, JPC = 9.0 Hz). 
31P NMR (121 MHz, CD3CN) δ 25.0, -144.9 (septet, JPF = 701.8 Hz). Anal. Calcd for 
C10H19F6N7O2P2: C, 26.98; H, 4.30; N, 22.02. Found: C, 26.77; H, 4.40; N, 21.87. 
4.4. 3-Nitro-1,2,4-triazol-1-yl-tris(pyrrolidin-1-yl)phosphonium hexafluorophosphate 
(PyNTP) 2 
  To powdery NaH (0.254 g, 10.5 mmol), prepared from NaH dispersion in mineral oil prior 
to use, was added a solution of 3-nitro-1,2,4-triazole (1.14 g, 10 mmol), which was dried by 
repeated coevaporations with dry pyridine and dry toluene, in dry THF (40 mL) at rt under 
argon. The mixture was then added a solution of PyClop (9) (4.22 g, 10 mmol) in dry THF 
(10 mL) at rt, and the mixture was stirred for 2 h. The insoluble solid was filtered off and 
thoroughly washed with dry CH2Cl2 (ca. 50 mL). The combined filtrate was concentrated 
under reduced pressure to some extent (ca. 20 mL) and cooled to 0 ˚C. The resultant 
precipitate was collected by suction filtration, washed with a small amount of THF, and dried 
under vacuum to afford 2 (4.19 g, 8.4 mmol, 84%) as a colorless crystals. Mp. 161-163 ˚C 
(decomp.). IR (KBr) 3118, 2984, 2880, 1566, 1510, 1285, 1143, 854, 590, 557 cm-1. 1H NMR 
(300 MHz, CD3CN) δ 8.79 (s, 1H), 3.40 (m, 12H), 2.03 (m, 12H). 13C NMR (75 MHz, 
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CD3CN) δ 165.5, 151.7 (d, JPC = 8.3 Hz), 49.0 (d, JPC = 4.9 Hz), 26.5 (d, JPC = 9.2 Hz). 31P 
NMR (121 MHz, CD3CN) δ 19.3, -142.5 (septet, JPF = 698.8 Hz). Anal. Calcd for 
C14H25F6N7O2P2: C, 33.67; H, 5.05; N, 19.64. Found: C, 33.76; H, 5.03; N, 19.58. 
4.5. 31P NMR monitoring of the condensation reactions of dimethyl phosphate or its 
analogs (10a-d) with 2-phenylethanol 11 in the presence of the phosphonium-type 
condensing reagents 
  150 µmol of 1, 2, or 3 was placed in an NMR sample tube and dried under vacuum over 
P2O5. Dry CD3CN (100 µL), an anhydrous CH3CN solution of triethylammonium dimethyl 
phosphate (10a) or one of its analogs (10b-d) (50 µmol), which was dried by repeated 
coevaporations with dry CH3CN (400 µL), dry 2-phenylethanol (11) (9.0 µL, 75 µmol), and 
distilled 2,6-lutidine (58.2 µL, 500 µmol) were added. The sample tube was then sealed, 
shaken to dissolve the condensing reagent. After 1.5 min, the 31P NMR data accumulation 
was started. Each accumulation was carried out over 1.5 min at every time-point of 3, 5, 15, 
20, 40, 50, 70, 90, 110, 130, and 150 min (Figures 3 and 6). 
4.6. Dimethyl 2-phenylethyl phosphate 12a 
  After the 31P NMR experiment, the reaction mixture was diluted with CH2Cl2 (3 mL) and 
washed with a 1 M HCl aqueous solution (3 × 3 mL). The combined aqueous layers were 
back-extracted with CH2Cl2 (3 mL), and the combined organic layers were washed with a 
saturated NaCl aqueous solution (2 × 3 mL). The combined aqueous layers were 
back-extracted with CH2Cl2 (3 mL), and the combined organic layers were dried over Na2SO4, 
filtered, and concentrated to dryness. The residue was purified by silica gel column 
chromatography [hexane/ethyl acetate (1/1, v/v)] to afford 12a (11.3 mg, 49 µmol, 98%) as a 
colorless oil. 1H, 13C, and 31P NMR spectra were identical to those reported in the literature.37  
4.7. Methyl 2-phenylethyl methylphosphonate 12b 
  After the 31P NMR experiment, the reaction mixture was diluted with CH2Cl2 (3 mL), 
washed with 0.2 M phosphate buffer (pH 7) (3 × 3 mL). The combined aqueous layers were 
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back-extracted with CH2Cl2 (3 mL), and the combined organic layers were dried over Na2SO4, 
filtered, and concentrated to dryness. The residue was purified by silica gel column 
chromatography [hexane/ethyl acetate (1/1, v/v)] to afford 12b (10.6 mg, 49 µmol, 99%) as a 
colorless oil. IR (film) 3444, 2956, 1645, 1497, 1455, 1313, 1231, 1016, 912, 818, 701 cm-1. 
1H NMR (300 MHz, CDCl3) δ 7.29-7.20 (m, 5H), 4.23 (m, 2H), 3.61 (d, JPH = 11.1 Hz, 3H), 
2.98 (t, J = 6.9 Hz, 2H), 1.38 (d, JPH = 17.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 137.2, 
128.9, 128.4, 126.6, 66.1 (d, JPC = 6.3 Hz), 37.1 (d, JPC = 6.3 Hz), 11.4, 9.5. 31P NMR (121 
MHz, CDCl3) δ 33.0. FAB-HRMS: m/z calcd for C10H15O3P (M+) 214.0759, found 214.0752. 
4.8. Dimethyl 2-phenylethyl boranophosphate 12c 
  After the 31P NMR experiment, the reaction mixture was diluted with CH2Cl2 (3 mL), 
washed with 0.2 M phosphate buffer (pH 7) (3 × 3 mL). The combined aqueous layers were 
back-extracted with CH2Cl2 (3 mL), and the combined organic layers were dried over Na2SO4, 
filtered, and concentrated to dryness. The residue was purified by silica gel column 
chromatography [hexane/ethyl acetate (4/1, v/v)] to afford 12c (11.4 mg, 50 µmol, quant) as a 
colorless oil. IR (film) 2955, 2396, 1455, 1260, 1028, 798, 700 cm-1. 1H NMR (300 MHz, 
CDCl3) δ 7.30-7.20 (m, 5H), 4.20 (q, J = 7.1 Hz, 2H), 3.61 (d, JPH = 11.1 Hz, 6H), 2.98 (t, J = 
7.1 Hz, 2H), 0.42 (brq, 3H). 13C NMR (75 MHz, CDCl3) δ 136.8, 128.8, 128.3, 126.5, 67.1 (d, 
JPC = 3.4 Hz), 52.9 (d, JPC = 3.5 Hz), 36.8 (d, JPC = 5.5 Hz). 31P NMR (121 MHz, CDCl3) δ 
117.7 (q, JPB = 99.1 Hz). FAB-HRMS: m/z calcd for C10H18BO3P (M+) 228.1089, found 
228.1094. 
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